Ameriprise’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $441K | Sell |
113,875
-1,330,057
| -92% | -$5.15M | ﹤0.01% | 3538 |
|
|
2025
Q1 | $7.22M | Sell |
1,443,932
-3,810,966
| -73% | -$19.1M | ﹤0.01% | 2013 |
|
|
2024
Q4 | $37.9M | Buy |
5,254,898
+1,378,854
| +36% | +$9.94M | 0.01% | 984 |
|
|
2024
Q3 | $23.8M | Buy |
3,876,044
+652,047
| +20% | +$4M | 0.01% | 1222 |
|
|
2024
Q2 | $21.4M | Buy |
3,223,997
+1,514,693
| +89% | +$10.1M | 0.01% | 1234 |
|
|
2024
Q1 | $17.4M | Sell |
1,709,304
-2,474,378
| -59% | -$25.2M | ﹤0.01% | 1389 |
|
|
2023
Q4 | $47.1M | Buy |
4,183,682
+4,172,791
| +38,314% | +$46.9M | 0.01% | 803 |
|
|
2023
Q3 | $28.3K | Sell |
10,891
-764
| -7% | -$1.99K | ﹤0.01% | 3859 |
|
|
2023
Q2 | $41.1K | Sell |
11,655
-1,047
| -8% | -$3.7K | ﹤0.01% | 3870 |
|
|
2023
Q1 | $53.6K | Sell |
12,702
-930
| -7% | -$3.93K | ﹤0.01% | 3863 |
|
|
2022
Q4 | $224K | Buy |
+13,632
| New | +$224K | ﹤0.01% | 3676 |
|
|
2021
Q2 | – | Sell |
-31,382
| Closed | -$443K | – | 3879 |
|
|
2021
Q1 | $443K | Buy |
+31,382
| New | +$443K | ﹤0.01% | 3449 |
|
|
2017
Q2 | – | Sell |
-54
| Closed | -$11K | – | 3710 |
|
|
2017
Q1 | $11K | Buy |
+54
| New | +$11K | ﹤0.01% | 3584 |
|